ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹179 Cr | ₹153 Cr | ₹161 Cr | ₹131 Cr | ₹139 Cr |
What is the latest Total Current Liabilities ratio of ANUH PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹179 Cr |
| Mar2024 | ₹153 Cr |
| Mar2023 | ₹161 Cr |
| Mar2022 | ₹131 Cr |
| Mar2021 | ₹139 Cr |
How is Total Current Liabilities of ANUH PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹179 Cr | 16.91 | |
| Mar2024 | ₹153 Cr | -5.36 | |
| Mar2023 | ₹161 Cr | 23.24 | |
| Mar2022 | ₹131 Cr | -6.14 | |
| Mar2021 | ₹139 Cr | - | |
Compare Total Current Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹797.3 Cr | 4.9% | 2.3% | -24.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,667.0 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,805.0 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| CIPLA | ₹109,120.0 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,920.0 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | 4.9% |
2.3% |
-24.9% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses